Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recce Pharmaceuticals
(OP:
RECEF
)
N/A
UNCHANGED
Last Price
Updated: 9:31 AM EDT, May 8, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Recce Pharmaceuticals
Recce Pharmaceuticals doses highest cohort in phase I/II UTI/Urosepsis trial
May 16, 2024
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) managing director and CEO James Graham talks with Proactive’s Jonathan Jackson about how Recce has administered the first doses in the latest cohort of...
Via
TheNewswire.com
Recce Pharma welcomes approval for faster RECCE327 infusion rate
October 26, 2023
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham tells Proactive the company has been given the green light by an independent safety committee for the next cohort dosing of RECCE® 327...
Via
TheNewswire.com
Recce Pharma says commercial potential of its anti-infectives is gaining recognition
October 11, 2023
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham speaks with Proactive soon after announcing the company has raised a total of around $11 million across its recent placement, entitlement...
Via
TheNewswire.com
Recce Pharma begins dosing in diabetic foot infection trial
August 23, 2023
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham tells Proactive the company has dosed patients in a Phase I/II diabetic foot infection (DFI) clinical trial, testing the safety and...
Via
TheNewswire.com
Recce Pharmaceuticals provides new hope in fight against superbugs
August 10, 2023
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) CEO James Graham speaks with Proactive after welcoming positive clinical responses to a new gel formulation of its R327® drug candidate, covered by the...
Via
TheNewswire.com
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.